CN103445911A - Method of allowing external-use drug to release slowly among toes - Google Patents
Method of allowing external-use drug to release slowly among toes Download PDFInfo
- Publication number
- CN103445911A CN103445911A CN 201210181576 CN201210181576A CN103445911A CN 103445911 A CN103445911 A CN 103445911A CN 201210181576 CN201210181576 CN 201210181576 CN 201210181576 A CN201210181576 A CN 201210181576A CN 103445911 A CN103445911 A CN 103445911A
- Authority
- CN
- China
- Prior art keywords
- toe
- drug
- medicine
- toes
- foot
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Abstract
The invention discloses a method of allowing external-use drug to release slowly among toes. According to the method, drug and toe sleeve are included. The method is characterized in that the drug is adhesive to the toe sleeve by own. The toe sleeve with the drug is adaptable to treating deceases on the toes, specially chronic and stubborn diseases, such as ringworms of the foot. The toe sleeve with adhesive external-use drug is sleeved on the toe to allow the drug to stay at the position for several tens of hours and plays promised effect through long-time releasing, better treatment effect is promoted, and the method is an idle one of using external-use drug for treating ringworms of the foot and other deceases of foot.
Description
Technical field
The present invention relates to the method for a kind of medicine for external use at the affected part slow release, particularly a kind ofly can make the method for medicine for external use at toe foot bifurcation place slow release.
Background technology
Treatment toe foot bifurcation disease is used medicine for external use has certain difficulty than other positions of health, especially allows medicine in some time of this director, and its effect difficulty of slow release is larger.Sometimes people have to make medicinal liquid and directly clean at toe foot bifurcation place, but this will soon kill, because of medicinal liquid, toe foot bifurcation place's time of staying is short, effect that play is very undesirable so exactly, has therefore just caused sick being difficult to of the toe foot bifurcations such as tinea pedis to cure within the time of rationalization scheme.
Summary of the invention
Purpose of the present invention is exactly to provide a kind of medicine for external use that can make slowly to discharge the method for the efficacy of a drug than the time length of directly cleaning stop with medicinal liquid at toe foot bifurcation place, overcomes the deficiencies in the prior art.
The technical solution of the inventive method is: a kind ofly can make the method for medicine for external use at toe foot bifurcation place slow release, it comprises medicine, toe binding, it is characterized in that: the toe binding that self is adhering to medicine.
Describedly can make the method for medicine for external use at toe foot bifurcation place slow release, it is characterized in that: the toe binding that the medication immersion is wet.
The present invention kills and compares soon with medicinal liquid with existing after clean at toe foot bifurcation place, the time that the present invention can make medicine stop in affected part equals existing time length of with medicinal liquid, directly in affected part, cleaning stop more than tens times, and the sick medicine for external use application method of this existing toe foot bifurcation can't compare.
The accompanying drawing explanation
Accompanying drawing is the article schematic diagram of the inventive method:
The specific embodiment
As shown be: toe binding, the manufactured materials of this dispenser articles for use can adopt textile, Cotton Gossypii etc.
Make the rear employing mode such as carry secretly and make it adhere to medicine, the method that wherein also available medicinal liquid soaks, make it adhere to medicine.After soaking, also can seal up, in order to directly wet use, as when needed the toe binding that medicinal liquid soaks is enclosed within on toe.So just can make toe, foot bifurcation place together obtain medicine stops at least tens hours at this place and reaches medicine in the slow purpose that discharges the efficacy of a drug of this director's time.
If do not adopt toe binding as shown in the figure, adopt the wide 2 centimetres of left and right with the toe binding same material, the strip tape of long 10 centimetres of left and right, through medicinal liquid, soak, directly be wrapped on toe when needed, or adopt cotton balls etc., be clipped in foot bifurcation place or make after medicinal liquid soaks and can pack into the toe binding that five toes are large or make without legging, after medicinal liquid soaks, directly wet use, also can play same effect.
Claims (2)
1. one kind can make the method for medicine for external use at toe foot bifurcation place slow release, and it comprises medicine, toe binding, it is characterized in that: the toe binding that self is adhering to medicine.
2. according to claim 1ly can make the method for medicine for external use at toe foot bifurcation place slow release, it is characterized in that: the toe binding that the medication immersion is wet.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210181576 CN103445911A (en) | 2012-06-01 | 2012-06-01 | Method of allowing external-use drug to release slowly among toes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210181576 CN103445911A (en) | 2012-06-01 | 2012-06-01 | Method of allowing external-use drug to release slowly among toes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103445911A true CN103445911A (en) | 2013-12-18 |
Family
ID=49729039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210181576 Pending CN103445911A (en) | 2012-06-01 | 2012-06-01 | Method of allowing external-use drug to release slowly among toes |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103445911A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113081483A (en) * | 2021-04-02 | 2021-07-09 | 李新亚 | Medical medicine envelope |
-
2012
- 2012-06-01 CN CN 201210181576 patent/CN103445911A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113081483A (en) * | 2021-04-02 | 2021-07-09 | 李新亚 | Medical medicine envelope |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR109605A2 (en) | METHOD FOR TREATING PERIPHERAL VASCULAR DISEASES, COMPOSITION AND USE | |
| CL2009001077A1 (en) | Polymeric particulate carrier comprising a biological agent in aqueous phase in a hollow lumen; procedure to deliver a protein to the eye; pharmaceutical composition comprising said vehicle; and its use for prophylaxis and treating diseases or disorders of the eye. | |
| CY1122628T1 (en) | USE OF ECHO-PENTAENOIC ACID ETHYL ESTER FOR THE TREATMENT OF HYPERTRIGLYCERIDEMIA | |
| TR201818927T4 (en) | Improvement in Catheters | |
| CY1124910T1 (en) | METHODS AND COMPOSITIONS FOR CNS DELIVERY OF ARYLOSULFATASE A | |
| EA201100335A1 (en) | PURIN DERIVATIVES FOR USE IN THE TREATMENT OF FAB-ASSOCIATED DISEASES | |
| WO2010068281A3 (en) | Contact lens drug delivery device | |
| EA201300121A1 (en) | DPP-4 INHIBITOR IN A COMBINATION WITH AN ADDITIONAL ANTI-DIABETIC AGENT, TABLETS INCLUDING THE SPECIFIED COMPOSITIONS, THEIR APPLICATION AND METHOD OF THEIR PREPARATION | |
| MY188825A (en) | High-concentration monoclonal antibody formulations | |
| WO2014102613A3 (en) | Device for disposal and neutralization of pharmaceutical agents | |
| AR097556A1 (en) | USE OF A COMBINATION OF A MEK INHIBITOR AND ERK INHIBITOR FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES | |
| ES2542042R1 (en) | Pharmaceutical compositions and use to prepare a drug for the treatment of obesity, related metabolic disorders and addiction to psychoactive substances | |
| AR082312A1 (en) | A PHARMACEUTICAL COMBINATION COMPOSITION TO TREAT DIABETES AND METABOLIC DISORDERS | |
| AR088585A1 (en) | A MEDICINAL PRODUCT TO TREAT THE PREVIOUS EYE DISEASE | |
| CL2014003148A1 (en) | Aqueous pharmaceutical composition containing a biological therapeutic agent and guanidine or a guanidine derivative and an injection that includes the composition. | |
| AR048342A1 (en) | PHARMACEUTICAL DOSAGE FORMS THAT INCLUDE THE N- (2- (2-FTHALIMIDOETOXI) -ACETILE) -L-ALANIL-D-GLUTAMIC ACID (LK-423) | |
| BR112016002251A2 (en) | drug delivery device | |
| WO2014036556A3 (en) | Drug delivery systems and methods for treatment of prostate disease comprising gemicitabine | |
| CL2014002706A1 (en) | Vesicular formulations comprising a phospholipid and a surface active agent and the use in the treatment of pain or reduced mobility of a joint. | |
| JP2013526960A5 (en) | ||
| CN103445911A (en) | Method of allowing external-use drug to release slowly among toes | |
| CL2010001594A1 (en) | Use of nifurtimox to prepare a medicine useful in the treatment of diseases caused by trichomonadide. | |
| AR109946A1 (en) | ARTIFICIAL PANTS | |
| EA201500765A1 (en) | METHODS OF TREATING CARDIOVASCULAR DISEASES | |
| ATE546159T1 (en) | NEW DRUG COMBINATIONS FOR THE TREATMENT OF RESPIRATORY DISEASES CONTAIN LONG-ACTING BETA-2 AGONISTS AND AT LEAST ONE OTHER ACTIVE INGREDIENTS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20131218 |